Radix sophorae flavescentis and / or extract thereof, composition, kit or combination product for myopia prevention and control

By combining the use of coriander root products and their extracts with atropine sulfate eye drops, the problem of visual fatigue side effects caused by low-concentration atropine eye drops has been solved, achieving the effect of effectively controlling myopia progression and improving compliance.

CN122097441APending Publication Date: 2026-05-29NATURAL MEDICINE INST OF ZHEJIANG YANGSHENGTANG

Patent Information

Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
NATURAL MEDICINE INST OF ZHEJIANG YANGSHENGTANG
Filing Date
2024-11-29
Publication Date
2026-05-29

AI Technical Summary

Technical Problem

In existing technologies, low-concentration atropine eye drops can cause visual fatigue as a side effect when controlling myopia progression, and the compliance rate among adolescent myopia patients is low. There is a lack of effective oral products on the market to control myopia progression.

Method used

Provide products of coriander root and its extracts, and prepare drugs or health foods for oral administration or in combination with atropine sulfate eye drops, for the prevention and control of refractive errors and relief of eye fatigue.

Benefits of technology

It can significantly control the progression of myopia, alleviate the side effects of eye strain, improve the safety and compliance of treatment plans, and enhance the effectiveness of myopia prevention and control.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure SMS_1
    Figure SMS_1
  • Figure SMS_2
    Figure SMS_2
  • Figure SMS_3
    Figure SMS_3
Patent Text Reader

Abstract

The present application relates to the field of food and medicine, and particularly relates to a horse radish and / or extract thereof, a composition, a medicine box or a combination product for myopia prevention and control. The horse radish and / or extract thereof can effectively prevent and control myopia, and when combined with atropine sulfate, the concentration of atropine sulfate can be significantly reduced, side effects such as asthenopia are reduced, and the safety of the medicine is improved.
Need to check novelty before this filing date? Find Prior Art